In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …

Cancer is a dreadful disease with a high mortality rate, and it has become more and more
prevalent worldwide. Early diagnosis, prognosis and treatment monitoring with robust and …

Cancer is the second most fatal disease in the world and an early diagnosis is important for
a successful treatment. Thus, it is necessary to develop fast, sensitive, simple, and …

Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …

Prostate cancer (PCa) is by far the most commonly diagnosed cancer in men worldwide.
Despite sensitivity to androgen deprivation, patients with advanced disease eventually …

Solid cancers are one of the leading causes of cancer related deaths, characterized by rapid
growth of tumour, and local and distant metastases. Current advances on multimodality care …

Early detection and diagnostics are essential for the cure of cancer which has high mortality
rate globally. In recent decades, various methods such as mammography, computed …

Background The lack of sensitive and specific biomarkers for the early detection of prostate
cancer (PCa) is a major hurdle to improve patient management. Methods A metabolomics …

Prostate cancer is one of the most frequently diagnosed malignancies in developed
countries and approximately 248,530 new cases of prostate cancer are likely to be …

Molecular sensors respond to target molecules in their surroundings to detect and
sometimes even quantify their concentrations. Traditionally comprised of small organic …